Saturday, September 24, 2016 8:00:05 AM
To say the least. We have so much potential to be a great company and near term, it's going to be in the hands of a Texas judge. If he rules against Navidea, investors will run for the exits and beambe's prediction of .75 may very well come true. In the Ohio document, it states in part that "without intervention from the Texas court such predatory and bad faith actions will likely preclude the sale to Cardinal as any sale of this magnitude requires the assets to be free from all liens."
THAT is how important this ruling is. This whole deal with Cardinal could fall apart and NAVB will be forced to try to get it appealed over the next few months. Stock price will plummet.
This is not fair and it's not right. NAVB is just trying to pay back its loan but CRG wants more than that - they don't want to just have their loan repaid, they want to run them out of business. No company in their right mind should ever deal with CRG ever again. They are a corrupt, greedy entity who wants blood. The judge should laugh them out of the court but I am not sure what the terms of agreement were and what the letter of the loan stated. It's up to him.
The judge SHOULD side with NAVB but we are unsure and that is why the stock took a hit and many investors bailed. I think if he rules for NAVB, everything moves forward. The loan finally gets paid and the company moves on to clearer skies and the stock rebounds over 1.20 near term and 1.50 in the next month or two. If the ruling is favorable, many people will come back.
But make no mistake, Monday's ruling plays a huge part in NAVB's future. If you can, keep some powder dry in case we get that favorable ruling and get in as fast as you can!
Your thoughts, Beambe??
Recent NAVB News
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 12/21/2023 08:32:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 11:26:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2023 04:49:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 09:55:52 PM
- Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities • Edgar (US Regulatory) • 10/23/2023 05:56:24 PM
- Navidea Biopharmaceuticals, Inc. Announces NYSE American’s Decision to Suspend Trading In Its Common Stock • Business Wire • 10/06/2023 01:01:00 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/05/2023 08:21:49 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 09/15/2023 07:42:35 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/11/2023 04:15:30 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/15/2023 09:53:39 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 08:06:00 PM
- Navidea Biopharmaceuticals, Inc. NAVB Requests Oral Hearing With NYSE Hearing Panel • Business Wire • 08/10/2023 01:29:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2023 08:23:49 PM
- Navidea Biopharmaceuticals, Inc. Presses Ahead, Embraces Opportunities • Business Wire • 07/31/2023 01:32:00 PM
- Navidea Biopharmaceuticals, Inc. Announces NYSE American Has Commenced Delisting Proceedings and Intent to Appeal NYSE American Determination • Business Wire • 07/29/2023 12:23:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/28/2023 09:10:53 PM
- Navidea Biopharmaceuticals, Inc. Hires Craig A. Dais, CPA as Chief Financial Officer • Business Wire • 07/27/2023 09:20:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/17/2023 10:02:51 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 07/17/2023 10:00:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 09:27:36 PM
- Navidea Biopharmaceuticals, Inc. Welcomes Dana J Moss, JD to Board of Directors; Amit Bhalla Steps Down • Business Wire • 07/13/2023 09:09:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/06/2023 08:39:03 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 07/03/2023 09:30:38 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 07/03/2023 08:01:04 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 06/30/2023 08:01:34 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM